The multifaceted role of MUC1 in tumor therapy resistance
- 23 December 2022
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (5) , 1441-1474
Abstract
Tumor therapeutic resistances are frequently linked to the recurrence and poor prognosis of cancers and have been a key bottleneck in clinical tumor treatment. Mucin1 (MUC1), a heterodimeric transmembrane glycoprotein, exhibits abnormally overexpression in a variety of human tumors and has been confirmed to be related to the formation of therapeutic resistance. In this review, the multifaceted roles of MUC1 in tumor therapy resistance are summarized from aspects of pan-cancer principles shared among therapies and individual mechanisms dependent on different therapies. Concretely, the common mechanisms of therapy resistance across cancers include interfering with gene expression, promoting genome instability, modifying tumor microenvironment, enhancing cancer heterogeneity and stemness, and activating evasion and metastasis. Moreover, the individual mechanisms of therapy resistance in chemotherapy, radiotherapy, and biotherapy are introduced. Last but not least, MUC1-involved therapy resistance in different types of cancers and MUC1-related clinical trials are summarized. Graphical abstractKeywords
This publication has 229 references indexed in Scilit:
- Tn and sialyl‐Tn antigens, aberrant O‐glycomics as human disease markersProteomics – Clinical Applications, 2013
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genesOncogenesis, 2013
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approachesOncogene, 2012
- Targeting of macrophage galactose‐type C‐type lectin (MGL) induces DC signaling and activationEuropean Journal of Immunology, 2012
- MUC1 regulates PDGFA expression during pancreatic cancer progressionOncogene, 2012
- Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathwayOncogene, 2011
- The role of tumor hypoxia in MUC1-positive breast carcinomasVirchows Archiv, 2011
- MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13Laboratory Investigation, 2011
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transitionOncogene, 2010
- The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGFOncogene, 2010